Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.2780
+0.0068 (2.51%)
At close: Dec 5, 2025, 4:00 PM EST
0.2700
-0.0080 (-2.88%)
After-hours: Dec 5, 2025, 7:34 PM EST
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $15.75 million as of December 5, 2025. Its market cap has increased by 443.00% in one year.
Market Cap
15.75M
Enterprise Value
9.44M
1-Year Change
443.00%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $15.75M, a decrease of -54.22%. That is a compound annual growth rate of -14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 15.70M | 441.38% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |